Tales of the Telomeres
DOI:
https://doi.org/10.46568/bios.v3i1.61Keywords:
Telomere Length, Aging, DNA damage responseReferences
Chakravarti D, LaBella KA, DePinho RA. Telomeres: history, health, and hallmarks of aging. Cell. 2021;184(2):306-22.
Matsumoto R, Fukuoka H, Iguchi G, Odake Y, Yoshida K, Bando H, et al. Accelerated Telomere Shortening in Acromegaly; IGF-I Induces Telomere Shortening and Cellular Senescence. PLoS One. 2015;10(10):e0140189.
Zane L, Ensminger DC. Short-term elevations in glucocorticoids do not alter telomere lengths: A systematic review and meta-analysis of non-primate vertebrate studies. 2021;16(10):e0257370.
Shin Y-A, Lee K-Y. Low estrogen levels and obesity are associated with shorter telomere lengths in pre- and postmenopausal women. J Exerc Rehabil. 2016;12(3):238-46.
Khosla S, Farr JN. The role of cellular senescence in ageing and endocrine disease. 2020;16(5):263-75.
Yang T, Wang H, Xiong Y, Chen C, Duan K, Jia J, et al. Vitamin D Supplementation Improves Cognitive Function Through Reducing Oxidative Stress Regulated by Telomere Length in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized Controlled Trial. Journal of Alzheimer's disease : JAD. 2020;78(4):1509-18.
Julin B, Shui IM, Prescott J, Giovannucci EL, De Vivo I. Plasma vitamin D biomarkers and leukocyte telomere length in men. European journal of nutrition. 2017;56(2):501-8.
Soundararajan A, Prabu P, Mohan V, Gibert Y, Balasubramanyam M. Novel insights of elevated systemic levels of bisphenol-A (BPA) linked to poor glycemic control, accelerated cellular senescence and insulin resistance in patients with type 2 diabetes. Molecular and cellular biochemistry. 2019;458(1-2):171-83.
Vaiserman A, Krasnienkov D. Telomere Length as a Marker of Biological Age: State-of-the-Art, Open Issues, and Future Perspectives. Frontiers in genetics. 2020;11:630186.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 BioSight
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright in their published work and grant BioSight the right of first publication.
All articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits others to read, download, copy, distribute, print, search, link to, adapt, and build upon the work for any lawful purpose, including commercial use, provided that appropriate credit is given to the author(s) and BioSight, a link to the license is provided, and any changes are clearly indicated.
Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of their work, provided that its initial publication in BioSight is acknowledged.
Publication in BioSight does not require authors to transfer copyright to the journal or publisher.
